Illumina, Siemens Forge Deal to Make HIV Test Compatible with MiSeq | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina and Siemens Healthcare Diagnostics have entered a partnership to make Siemens' molecular HIV tests compatible with the MiSeq platform and to set new standards for the use of next-generation sequencing for the identification of infectious diseases and potential treatments paths.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.